Our multi-platform analysis of TCGA and GEO datasets revealed consistent GPD1L downregulation in CRC tissues compared to normal mucosa (Figure 1), a finding validated in our institutional cohort (n=58 tumor-normal pairs; Figure 2a). This evidence concerns the gene GPD1L and colorectal carcinoma.